• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Final Thoughts

Feature
Video

Sponsored

The future of CAR T-cell therapies will continue to improve as they expand to other patients in need.

The panelists provide their closing thoughts on CAR T-cell therapies and what they look forward to as these therapies become popular beyond cancer, extending to autoimmune diseases as well. There is hope to remove manufacturing bottleneck so patient demand and access can improve.

Recent Videos
Related Content
Peer Exchange: AI’s Data Advantage

Peer Exchange: AI’s Data Advantage

Mike Hollan
December 20th 2024
Article

In the third part of this roundtable discussion, experts discuss the issues with data that AI must overcome.

Peer Exchange: Marketing With AI

Peer Exchange: Marketing With AI

Mike Hollan
December 13th 2024
Article

In the second part of this roundtable discussion, experts discuss how the industry is handling AI in the marketing space.

AI Adoption

Peer Exchange: Embracing AI in Pharma

Mike Hollan
December 6th 2024
Article

In this first part of this roundtable discussion, experts discuss the current perception of AI and how this is impacting adoption.

Today’s New Messaging Mix: The State of Pharma Marketing in 2024

Today’s New Messaging Mix: The State of Pharma Marketing in 2024

Mike Hollan
May 13th 2024
Article

Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is.

Roundtable: Current State of the Pharma Sales and Marketing Sales Force

Roundtable: Current State of the Pharma Sales and Marketing Sales Force

April 23rd 2024
Article
DOL KOL Roundtable

An Evolving ‘Opinion’ Landscape: New Paths—and Synergies—for Pharma KOLs & DOLs

Mike Hollan
October 13th 2023
Article

Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.